U.S. FDA

FDA
Favicon Fierce Pharma

George Tidmarsh exits as LinkedIn post sparks lawsuit, probe

A recent LinkedIn post has landed the now-departed CDER chief at the center of an Aurinia lawsuit and an internal probe.
Fraiser Kansteiner Nov 3, 2025 11:13am
uturn

uniQure's gene therapy for Huntington's hits FDA roadblock

Nov 3, 2025 10:03am
VanNaarden

Lilly oncology head weighs in on FDA cancer drug policies

Oct 21, 2025 11:53am
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Prasad exit signals more permissive FDA for cell and gene field

Jul 31, 2025 9:10am
FDA
Favicon Fierce Pharma

Vinay Prasad departs FDA amid controversy over gene therapy

Jul 30, 2025 9:33am
sarepta building
Favicon Fierce Pharma

FDA backtracks on Sarepta's gene therapy Elevidys in DMD

Jul 28, 2025 6:02pm